Your search returned 46 studies. (Get alerts for new studies):
- An Open-Label Study of Trastuzumab Emtansine (T-DM1) vs Capecitabine+Lapatinib in Patients With HER2-Positive Locally Advanced or Metastatic Breast Ca
Conditions: Breast Cancer
Location: Lafayette, Indiana
- A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Patients With Hormone Receptor-Positive, Metastatic HER2-positive
Conditions: Breast Cancer
Location: Lafayette, Indiana
- Carotid Stenting vs. Surgery of Severe Carotid Artery Disease and Stroke Prevention in Asymptomatic Patients (ACT I)
Conditions: Carotid Artery Disease - Carotid Stenosis - Stroke - Atherosclerosis
Location: Lafayette, Louisiana
- Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer
Conditions: Breast Cancer
Location: Lafayette, Louisiana
- A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Conditions: Atopic Dermatitis
Location: Opelousas, Louisiana
- 2 Week Open-label Pharmacodynamic and Pharmacokinetic Study of Multiple Doses of a Darifenacin Liquid Oral Suspension in Children (2 - 15 Yrs) With Ne
Conditions: Neurogenic Detrusor Overactivity
Location: Lafayette, Louisiana
- Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
Conditions: Pancreatic Cancer
Location: Baton Rouge, Louisiana
- A Study to Assess Whether PDE5 Inhibitors Increase the Chance of Triggering the Onset of Acute NAION
Conditions: Optic Neuropathy, Ischemic
Location: Lafayette, Louisiana
- A Study to Assess Whether PDE5 Inhibitors Increase the Chance of Triggering the Onset of Acute NAION
Conditions: Optic Neuropathy, Ischemic
Location: Lafayette, Louisiana
- Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Conditions: Type 2 Diabetes Mellitus
Location: Lafayette, Louisiana
- A Clinical Study to Evaluate Somo•v and Digital Mammography Together as a Breast Cancer Screening Method, Compared to Digital Mammography Alone, in Wo
Conditions: Breast Cancer
Location: Lafayette, Louisiana
- Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Conditions: Non-Small Cell Lung Cancer - Anemia - Cancer - Lung Cancer
Location: Lafayette, Louisiana
- A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus
Conditions: Diabetes Mellitus, Type 2
Location: Lafayette, Louisiana
- A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus
Conditions: Diabetes Mellitus, Type 2
Location: Opelousas, Louisiana
- Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Conditions: Schizophrenia - Bipolar Disorder
Location: Opelousas, Louisiana
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use NSAIDs and/or Colchicine.
Conditions: Acute Gout
Location: Lafayette, Louisiana
- A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional A
Conditions: Type 2 Diabetes
Location: Eunice, Louisiana
- Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Conditions: Postpartum Uterine Bleeding
Location: Lafayette, Louisiana
- PH III Relapse or Refractory MM - Open Label With or Without Elotuzumab
Conditions: Multiple Myeloma
Location: Lafayette, Louisiana
- Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Conditions: Atherosclerosis
Location: Lafayette, Louisiana
- Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Conditions: Atherosclerosis
Location: Lafayette, Louisiana
- Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Conditions: Atherosclerosis
Location: Lafayette, Louisiana
- Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Conditions: Atherosclerosis
Location: Opelousas, Louisiana
- A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
Conditions: Infection, Human Immunodeficiency Virus
Location: Lafayette, Louisiana
- Randomized Study of Laser and Balloon Angioplasty Versus Balloon Angioplasty to Treat Peripheral In-stent Restenosis
Conditions: Peripheral Arterial Disease
Location: Lafayette, Louisiana
- Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Newly Diagnosed, Previously Untreated Multiple Myeloma
Conditions: Multiple Myeloma
Location: Lafayette, Louisiana
- Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Conditions: Abscess - Wound Infection - Surgical Site Infection - Cellulitis
Location: Lafayette, Louisiana
- A Study of Pertuzumab in Addition to Chemotherapy and Herceptin (Trastuzumab) as Adjuvant Therapy in Patients With HER2-Positive Primary Breast Cancer
Conditions: Breast Cancer
Location: Lafayette, Louisiana
- A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent
Conditions: Major Depressive Disorder
Location: Shreveport, Louisiana
- Evaluate the Efficacy and Safety of GSK573719 Delivered Via a Novel Dry Powder Inhaler in Subjects With COPD
Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Location: Sunset, Louisiana
- Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Conditions: Asthma
Location: Sunset, Louisiana
- Efficacy, Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Formoterol Fumarate in Patients With Moderate to Severe Chro
Conditions: Chronic Obstructive Pulmonary Disease
Location: Opelousas, Louisiana
- Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled
Conditions: COPD - COPD Exacerbation - Lung Diseases - Respiratory Disorders - Pulmonary Disease - Chronic Obstructive Lung Diseases - Chronic Obstructive Airway Disease
Location: Lafayette, Louisiana
- Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled
Conditions: COPD - COPD Exacerbation - Lung Diseases - Respiratory Disorders - Pulmonary Disease - Chronic Obstructive Lung Diseases - Chronic Obstructive Airway Disease
Location: Opelousas, Louisiana
- Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled
Conditions: COPD - COPD Exacerbation - Lung Diseases - Respiratory Disorders - Pulmonary Disease - Chronic Obstructive Lung Diseases - Chronic Obstructive Airway Disease
Location: Sunset, Louisiana
- Observational Study of the Use of KRYSTEXXA® in Refractory Chronic Gout
Conditions: Chronic Gout
Location: Eunice, Louisiana
- A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Conditions: Asthma
Location: Sunset, Louisiana
- A Phase 3 Study Comparing the Effects of Subcutaneous Epoetin Hospira and Epoetin Alfa (Amgen) in Patients With Chronic Renal Failure Requiring Hemodi
Conditions: Chronic Renal Failure - Chronic Kidney Disease
Location: Lafayette, Louisiana
- A Phase 3 Study Comparing the Effects of Subcutaneous Epoetin Hospira and Epoetin Alfa (Amgen) in Patients With Chronic Renal Failure Requiring Hemodi
Conditions: Chronic Renal Failure - Chronic Kidney Disease
Location: Opelousas, Louisiana
- Study of Bortezomib and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma
Conditions: Multiple Myeloma
Location: Lafayette, Louisiana
- A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy
Conditions: Colorectal Cancer
Location: Lafayette, Louisiana
- A Study of ALKS 9072 in Subjects With Chronic Stable Schizophrenia
Conditions: Schizophrenia
Location: Irving, Texas
- Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypert
Conditions: Stage 1 Hypertension - Stage 2 Hypertension
Location: Eunice, Louisiana
- Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypert
Conditions: Stage 1 Hypertension - Stage 2 Hypertension
Location: Sunset, Louisiana
- Endovascular Atherectomy Safety and Effectiveness Study
Conditions: Peripheral Vascular Disease
Location: Lafayette, Louisiana
- 8-week Randomized, Open-label Study to Evaluate Food Effect on Efficacy and Safety of Oral Aliskiren 300 mg in Patients With Hypertension
Conditions: Hypertension
Location: Opelousas, Louisiana
|